Is leptin an independent risk factor for development of left ventricular hypertrophy in obese hypertensive patients?;Şişman hipertansif hastalarda leptin sol ventrikül hipertrofisi gelişimi için baǧimsiz bir risk faktörü müdür?

Anadolu Kardiyoloji Dergisi

Volumn 8, Issue 5, 2008, Pages 347-349

  Kiliç, Teoman ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LEPTIN;

ATHEROSCLEROSIS; DIASTOLIC BLOOD PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; NOTE; OBESITY; PROGNOSIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; BLOOD; BODY MASS; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL;

BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LEPTIN; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 56049123438     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (23)

1. Dubey L, Hesong Z. Role of leptin in atherogenesis. Exp Clin Cardiol 2006; 11: 269-75.
2. Woods AJ, Stock MJ. Leptin activation in hypothalamus. Nature 1996; 381: 745.
3. Ostlund RE Jr, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996; 81: 3909-13.
4. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 1311-4.
5. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31: 409-14.
6. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension 1997; 30: 619-23.
7. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270-8.
8. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: Role of leptin and sympathetic nervous system. Am J Hypertens 2001; 14: 103S-15S.
9. Adamczak M, Kokot F, Wiecek A. Relationship between plasma renin profile and leptinemia in patients with essential hypertension. J Hum Hypertens 2000; 14: 503-9.
10. Chambers J. Left ventricular hypertrophy. BMJ 1995; 311: 273-4.
11. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering T, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-8.
12. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
13. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham study. Ann Intern Med 1989; 110: 101-7.
14. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561-6.
15. Rowlands DB, Glover DR, Ireland MA, McLeay RAB, Stallard TJ, Watson RDS, et al. Assessment of left-ventricular mass and its response to antihypertensive treatment. Lancet 1987; 1: 467-70.
16. Lauer MS, Anderson KM, Levy D. Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham heart study. J Am Coll Cardiol 1991; 18: 1287-94.
17. Kartal Ö, Inal V, Baysan O, Saǧlam K. Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients. Anadolu Kardiyol Derg 2008: 8; 342-6.
18. Margetic S, Gazzola C, Pegg GG and Hill RA. Leptin: a review of its peripheral actions and interactions. Intern J of Obesity 2002; 26: 1407-33.
19. Nickola MW, Wold LE, Colligan PB Wang GJ Samson WK, Ren J. Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension 2000; 36: 501-5.
20. Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M. The obesity associated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003; 93: 277-9.
21. Tajmir P, Ceddia RB, Li RK, Coe IR, Sweeney S. Leptin increases cardiomyocytes hyperplasia via extracellular signal-regulated kinase and phosphatidylinositol 3 kinase dependent signaling pathways. Endocrinology 2004; 145: 1550-5.
22. Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003; 108: 754-9.
23. Perego L, Pizzocri P, Corradi D, Maisano F, Paganelli M, Fiorina P, et al. Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy. J Clin Endocrinol Metab 2005; 90: 4087-93.